Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.40 |
| ▸ | CARM1 | Q86X55 | 6/20 | 0.35 |
| ▸ | PRMT6 | Q96LA8 | 5/20 | 0.35 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1838443 | 0.88 | KDM4E (0.48) | KDM4EL3MBTL1DCPSQRFPRNPSR1 | |
| SCHEMBL1833410 | 0.88 | KDM4E (0.48) | KDM4EL3MBTL1DCPSQRFPRNPSR1 | |
| SCHEMBL1841324 | 0.88 | KDM4E (0.48) | KDM4EL3MBTL1DCPSQRFPRNPSR1 | |
| SCHEMBL1837187 | 0.86 | KDM4E (0.49) | KDM4EL3MBTL1DCPSCARM1PRMT6 | |
| SCHEMBL4965091 | 0.86 | KDM4E (0.46) | KDM4EL3MBTL1DCPSCARM1PRMT6 | |
| SCHEMBL1837953 | 0.79 | KDM4E (0.52) | KDM4EL3MBTL1QRFPRSCN9ANPC1 | |
| SCHEMBL1836426 | 0.79 | KDM4E (0.52) | KDM4EL3MBTL1QRFPRSCN9ANPC1 | |
| SCHEMBL1838623 | 0.79 | KDM4E (0.52) | KDM4EL3MBTL1QRFPRSCN9ANPC1 | |
| SCHEMBL1837026 | 0.78 | KDM4E (0.51) | KDM4EL3MBTL1NPSR1 | |
| SCHEMBL13806992 | 0.78 | EPHX2 (0.47) | KDM4EL3MBTL1CARM1PRMT6SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1314725-B1 | SULFONIUM SALT COMPOUND | WAKO PURE CHEM IND LTD (JP) | 2008-03-19 | — | — | EP | disclosed |
| US-6924323-B2 | Sulfonium salt compound | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2005-08-02 | — | — | US | disclosed |
| US-6723483-B1 | Sulfonium salt compounds | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2004-04-20 | — | — | US | disclosed |
| US-20040033434-A1 | Sulfonium salt compound | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2004-02-19 | — | — | US | disclosed |
| EP-1314725-A1 | SULFONIUM SALT COMPOUND | Wako Pure Chemical Industries, Ltd. (JP) | 2003-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040033434-A1 | Sulfonium salt compound | SPIN1, RER1, SPIN2B | KDM4E 1259/4885L3MBTL1 3356/4885DCPS 3755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.